Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial
Authors
Keywords
-
Journal
HYPERTENSION RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-14
DOI
10.1038/s41440-018-0165-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population
- (2018) Martin Bødtker Mortensen et al. ANNALS OF INTERNAL MEDICINE
- Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study
- (2017) Jodi D. Edwards et al. JOURNAL OF ALZHEIMERS DISEASE
- Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT Study
- (2017) Jessica Mira Gabin et al. Alzheimers Research & Therapy
- Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
- (2017) Nophar Geifman et al. Alzheimers Research & Therapy
- Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease
- (2017) Julie M. Zissimopoulos et al. JAMA Neurology
- Low carotid artery wall shear stress is independently associated with brain white-matter hyperintensities and cognitive impairment in older patients
- (2016) Zhendong Liu et al. ATHEROSCLEROSIS
- Colorectal Cancer Screening Recommendations—Reply
- (2016) Kirsten Bibbins-Domingo JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- White Matter Hyperintensities Are Under Strong Genetic Influence
- (2016) Perminder S. Sachdev et al. STROKE
- Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
- (2016) T. Michael De Silva et al. Frontiers in Pharmacology
- Tract-specific white matter degeneration in aging: The Rotterdam Study
- (2015) Marius de Groot et al. Alzheimers & Dementia
- Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective
- (2015) Matthew Baumgart et al. Alzheimers & Dementia
- Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old
- (2015) Zhendong Liu et al. HYPERTENSION RESEARCH
- A Low-Dose Combination of Fluvastatin and Valsartan: A New “Drug” and a New Approach for Decreasing the Arterial Age
- (2015) Miodrag Janić et al. Biomed Research International
- Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis
- (2014) Zhendong Liu et al. ATHEROSCLEROSIS
- The low-dose atorvastatin and valsartan combination effectively protects the arterial wall from atherogenic diet-induced impairment in the guinea pig
- (2014) Miodrag Janić et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Excessive Lowering of Blood Pressure Is Not Beneficial for Progression of Brain White Matter Hyperintensive and Cognitive Impairment in Elderly Hypertensive Patients: 4-Year Follow-Up Study
- (2014) Jie Peng et al. Journal of the American Medical Directors Association
- Associations Between Cerebral Small-Vessel Disease and Alzheimer Disease Pathology as Measured by Cerebrospinal Fluid Biomarkers
- (2014) Maartje I. Kester et al. JAMA Neurology
- The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F 2a levels
- (2013) Christos V. Rizos et al. Archives of Medical Science
- Oxidative stress and other risk factors for white matter lesions in chronic hemodialysis patients
- (2013) Mònica Muñoz-Cortés et al. CLINICAL NEPHROLOGY
- Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
- (2013) Joanna M Wardlaw et al. LANCET NEUROLOGY
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
- (2013) Joanna M Wardlaw et al. LANCET NEUROLOGY
- Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study
- (2012) Alex Dregan et al. AGE AND AGEING
- Trajectory of white matter hyperintensity burden preceding mild cognitive impairment
- (2012) L. C. Silbert et al. NEUROLOGY
- Telmisartan on Top of Antihypertensive Treatment Does Not Prevent Progression of Cerebral White Matter Lesions in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) MRI Substudy
- (2012) Ralph Weber et al. STROKE
- Antihypertensive Treatment and Change in Blood Pressure Are Associated With the Progression of White Matter Lesion Volumes
- (2011) Ophélia Godin et al. CIRCULATION
- Average Daily Blood Pressure, Not Office Blood Pressure, Is Associated With Progression of Cerebrovascular Disease and Cognitive Decline in Older People
- (2011) William B. White et al. CIRCULATION
- FSL
- (2011) Mark Jenkinson et al. NEUROIMAGE
- Effects of Statins on Progression of Subclinical Brain Infarct
- (2010) Jian Hui Fu et al. CEREBROVASCULAR DISEASES
- Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
- (2010) Leonardo Pantoni LANCET NEUROLOGY
- Hyperlipidemia and cerebral small-vessel disease
- (2010) Jessica R. L. Warsch et al. Nature Reviews Neurology
- Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral Hypoperfusion
- (2010) Kazuo Washida et al. STROKE
- Hyperlipidemia and Reduced White Matter Hyperintensity Volume in Patients With Ischemic Stroke
- (2010) Jordi Jimenez-Conde et al. STROKE
- Effects of statins on the progression of cerebral white matter lesion
- (2009) Vincent C. T. Mok et al. JOURNAL OF NEUROLOGY
- Placebo-Controlled Trial of High-Dose Atorvastatin in Patients With Severe Cerebral Small Vessel Disease
- (2009) Philippa C. Lavallée et al. STROKE
- Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study
- (2008) Hans-Christoph Diener et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started